ZTS Zoetis Inc

By Dave Sebastian

Zoetis Inc. said its profit and revenue rose for the second quarter, driven by its petcare parasiticides, key dermatology products, vaccines and diagnostics.

The animal-health company on Thursday posted net income attributable to the company of $512 million, compared with $377 million in the prior year. Earnings were $1.07 a share, compared with 79 cents a share in the year-ago period.

Adjusted earnings were $1.19 a share. Analysts polled by FactSet were expecting $1.09 a share.

Revenue rose 26% to $1.95 billion. Analysts were looking for $1.83 billion.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

August 05, 2021 07:37 ET (11:37 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.